Gilead Sciences
GILD
#93
Rank
NZ$307.33 B
Marketcap
NZ$247.57
Share price
-1.44%
Change (1 day)
22.00%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): NZ$17.01 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are NZ$29.08 Billion. In 2024 the company made an earning of NZ$1.16 Billion a decrease over its 2023 earnings that were of NZ$11.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$17.01 B1358.81%
2024 NZ$1.16 B-89.94%
2023 NZ$11.59 B17.97%
2022 NZ$9.83 B-29.77%
2021 NZ$13.99 B395.99%
2020 NZ$2.82 B-67.66%
2019 NZ$8.72 B-33.84%
2018 NZ$13.18 B-42.35%
2017 NZ$22.87 B-20.87%
2016 NZ$28.90 B-21.06%
2015 NZ$36.62 B45.8%
2014 NZ$25.11 B253.01%
2013 NZ$7.11 B16.51%
2012 NZ$6.10 B-1.07%
2011 NZ$6.17 B-6.71%
2010 NZ$6.61 B11.75%
2009 NZ$5.92 B29.5%
2008 NZ$4.57 B19.11%
2007 NZ$3.83 B-455.74%
2006 -NZ$1.08 Billion-154.93%
2005 NZ$1.96 B76.99%
2004 NZ$1.10 B-266.16%
2003 -NZ$0.67 Billion-638.24%
2002 NZ$0.12 B31.5%
2001 NZ$94.37 M-242.15%
2000 -NZ$66.4 Million-40.2%
1999 -NZ$0.12 Billion31.85%
1998 -NZ$84.21 Million8.73%
1997 -NZ$77.44 Million27.22%
1996 -NZ$60.87 Million
1994 -NZ$58 Million26.57%
1993 -NZ$45.83 Million46.49%
1992 -NZ$31.28 Million362.5%
1991 -NZ$6.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$54.77 B 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.03 B 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.80 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.04 B 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$13.93 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$3.21 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$1.68 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$7.54 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.04 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA